BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

184 related articles for article (PubMed ID: 28940572)

  • 61. Successful Management of Folliculitis Decalvans.
    Kashikar Y; Saoji V; Madke B; Chandak MS; Meghe S
    Cureus; 2024 Jan; 16(1):e52881. PubMed ID: 38406166
    [TBL] [Abstract][Full Text] [Related]  

  • 62. [Pityriasis amiantacea and folliculitis decalvans : An unusual manifestation associated with antitumor necrosis factor-α therapy].
    Zamperetti M; Zelger B; Höpfl R
    Hautarzt; 2017 Dec; 68(12):1007-1010. PubMed ID: 29038892
    [TBL] [Abstract][Full Text] [Related]  

  • 63. Porfimer sodium photodynamic therapy for management of Barrett's esophagus with high-grade dysplasia.
    Panjehpour M; Overholt BF
    Lasers Surg Med; 2006 Jun; 38(5):390-5. PubMed ID: 16788927
    [TBL] [Abstract][Full Text] [Related]  

  • 64. Folliculitis decalvans is characterized by a persistent, abnormal subepidermal microbiota.
    Matard B; Donay JL; Resche-Rigon M; Tristan A; Farhi D; Rousseau C; Mercier-Delarue S; Cavelier-Balloy B; Assouly P; Petit A; Bagot M; Reygagne P
    Exp Dermatol; 2020 Mar; 29(3):295-298. PubMed ID: 30907453
    [TBL] [Abstract][Full Text] [Related]  

  • 65. Enzyme activated photodynamic therapy for methicillin-resistant Staphylococcus aureus infection both inv itro and in vivo.
    Fu XJ; Zhu YQ; Peng YB; Chen YS; Hu YP; Lu HX; Yu WR; Fang Y; Du JZ; Yao M
    J Photochem Photobiol B; 2014 Jul; 136():72-80. PubMed ID: 24857792
    [TBL] [Abstract][Full Text] [Related]  

  • 66. Long term efficacy of Photodynamic Therapy (PDT) as an ablative therapy of high grade dysplasia in Barrett's oesophagus.
    Gray J; Fullarton GM
    Photodiagnosis Photodyn Ther; 2013 Dec; 10(4):561-5. PubMed ID: 24284112
    [TBL] [Abstract][Full Text] [Related]  

  • 67. Primary scarring alopecias.
    Rigopoulos D; Stamatios G; Ioannides D
    Curr Probl Dermatol; 2015; 47():76-86. PubMed ID: 26370646
    [TBL] [Abstract][Full Text] [Related]  

  • 68. TISSUE IMMUNE CELLS AND THEIR ROLE IN THE HEALING PROCESS OF INFECTED RADIATION ULCERS UNDER THE IMPACT OF PHOTODYNAMIC THERAPY (EXPERIMENTAL STUDY).
    Krasnoselsky MV; Simonova LI; Gertman VZ; Pushkar ES; Zavadskaya TS
    Probl Radiac Med Radiobiol; 2019 Dec; 24():250-260. PubMed ID: 31841471
    [TBL] [Abstract][Full Text] [Related]  

  • 69. Folliculitis decalvans treated with radiation therapy.
    Smith EP; Hardaway CA; Graham BS; Johnstone PA
    Cutis; 2006 Sep; 78(3):162-4. PubMed ID: 17036658
    [TBL] [Abstract][Full Text] [Related]  

  • 70. Photodynamic therapy using porfimer sodium as an alternative to cystectomy in patients with refractory transitional cell carcinoma in situ of the bladder. Bladder Photofrin Study Group.
    Nseyo UO; Shumaker B; Klein EA; Sutherland K
    J Urol; 1998 Jul; 160(1):39-44. PubMed ID: 9628601
    [TBL] [Abstract][Full Text] [Related]  

  • 71. Pilot study to assess patient outcomes following endoscopic application of photodynamic therapy for advanced cholangiocarcinoma.
    Harewood GC; Baron TH; Rumalla A; Wang KK; Gores GJ; Stadheim LM; de Groen PC
    J Gastroenterol Hepatol; 2005 Mar; 20(3):415-20. PubMed ID: 15740486
    [TBL] [Abstract][Full Text] [Related]  

  • 72. Isotretinoin treatment for folliculitis decalvans: a retrospective case-series study.
    Aksoy B; Hapa A; Mutlu E
    Int J Dermatol; 2018 Feb; 57(2):250-253. PubMed ID: 29313960
    [TBL] [Abstract][Full Text] [Related]  

  • 73. Folliculitis decalvans and tufted folliculitis are specific infective diseases that may lead to scarring, but are not a subset of central centrifugal scarring alopecia.
    Powell J; Dawber RP
    Arch Dermatol; 2001 Mar; 137(3):373-4. PubMed ID: 11255348
    [No Abstract]   [Full Text] [Related]  

  • 74. Folliculitis decalvans.
    Brooke RC; Griffiths CE
    Clin Exp Dermatol; 2001 Jan; 26(1):120-2. PubMed ID: 11260200
    [No Abstract]   [Full Text] [Related]  

  • 75. Tinea capitis mimicking folliculitis decalvans.
    Tangjaturonrusamee C; Piraccini BM; Vincenzi C; Starace M; Tosti A
    Mycoses; 2011 Jan; 54(1):87-8. PubMed ID: 19638002
    [TBL] [Abstract][Full Text] [Related]  

  • 76. The effect of fluence rate on tumor and normal tissue responses to photodynamic therapy.
    Sitnik TM; Henderson BW
    Photochem Photobiol; 1998 Apr; 67(4):462-6. PubMed ID: 9559590
    [TBL] [Abstract][Full Text] [Related]  

  • 77. Evidence for different mechanisms of EMT-6 tumor necrosis by photodynamic therapy with disulfonated aluminum phthalocyanine or photofrin: tumor cell survival and blood flow.
    Chan WS; Brasseur N; La Madeleine C; van Lier JE
    Anticancer Res; 1996; 16(4A):1887-92. PubMed ID: 8712717
    [TBL] [Abstract][Full Text] [Related]  

  • 78. Agr function is upregulated by photodynamic therapy for Staphylococcus aureus and is related to resistance to photodynamic therapy.
    Park HJ; Moon YH; Yoon HE; Park YM; Yoon JH; Bang IS
    Microbiol Immunol; 2013 Aug; 57(8):547-52. PubMed ID: 23668640
    [TBL] [Abstract][Full Text] [Related]  

  • 79. Successful treatment of refractory folliculitis decalvans with secukinumab.
    Ismail FF; Sinclair R
    Australas J Dermatol; 2020 May; 61(2):165-166. PubMed ID: 31646619
    [No Abstract]   [Full Text] [Related]  

  • 80. Adjuvant photodynamic therapy for bile duct carcinoma after surgery: a preliminary study.
    Nanashima A; Yamaguchi H; Shibasaki S; Ide N; Sawai T; Tsuji T; Hidaka S; Sumida Y; Nakagoe T; Nagayasu T
    J Gastroenterol; 2004 Nov; 39(11):1095-101. PubMed ID: 15580404
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.